Nabla is a healthcare technology company founded in 2018 that specializes in AI-powered clinical documentation solutions. The company offers an ambient artificial intelligence assistant designed to automate and streamline the documentation process for clinicians during patient consultations. Their technology generates real-time, structured clinical notes that integrate directly into electronic health records (EHR) systems, significantly reducing the time physicians spend on paperwork and allowing them to focus more on patient care.
Headquartered in Paris, France, Nabla also maintains an office in the United States, indicating its presence in key global markets. The company supports over 55 medical specialties and is trusted by more than 85,000 clinicians, demonstrating broad applicability across healthcare fields. Nabla’s leadership team comprises entrepreneurs, engineers, and physicians with backgrounds at major technology companies such as Facebook AI Research and Wit.ai, highlighting a strong focus on cutting-edge AI innovation.
Nabla’s mission is encapsulated in the tagline “Enjoy care again,” reflecting their commitment to transforming medical practice through AI-augmented care and making healthcare delivery more efficient and clinician-friendly. With funding rounds including a recent Series C and a total capital raise exceeding $44 million, Nabla is positioned as a growing player in the healthtech space, recognized for improving clinical documentation quality and workflow.
The company’s product suite supports diverse clinical workflows by providing templates and AI-powered assistance tailored to various health care specialties. Their solution aims to enhance accuracy and efficiency in medical note-taking, thereby improving overall patient care and operational efficiency in healthcare organizations.
Nabla embodies a fusion of medical expertise and artificial intelligence, striving to revolutionize the clinician’s experience and the documentation landscape in health care through smart, integrated technology solutions.